Literature DB >> 10452361

Developmental regulation of glutamate transporters and glutamine synthetase activity in astrocyte cultures differentiated in vitro.

D B Stanimirovic1, R Ball, D L Small, A Muruganandam.   

Abstract

Glutamate plays an important role in brain development, physiological function, and neurodegeneration. Astrocytes control synaptic concentration of glutamate via the high affinity glutamate transporters, GLT-1 and GLAST, and the glutamate catabolizing enzyme, glutamine synthetase. In this study we show that astrocytes cultured from rat brain in various stages of development including embryonic (E18), postnatal (P1-P21) and mature (P50), show distinct patterns of GLT-1 and GLAST expression, glutamine synthetase activity, and phenotypic changes induced by dibutyryl-cyclic adenosine monophosphate. The transcripts for GLT-1 message were detectable in embryonic astrocytes only, whereas the GLAST message was highly expressed in E18 and P1-P4 astrocyte cultures, declined in P10-P21, and was undetectable in P50 astrocytes. Uptake of 3H-glutamate correlated well with GLAST expression in astrocyte cultures of all developmental stages. Glutamine synthetase activity significantly declined from high embryonic levels in P4 astrocytes and remained low throughout postnatal maturation. Exposure of astrocyte cultures to the differentiating agent, db-cAMP (250-500 microM; 6 days), resulted in a pronounced stellation, up-regulation of GLT-1 and GLAST in E18, and GLAST in P4 cultures, while it was ineffective in P10 astrocytes. By contrast, db-cAMP induced a more pronounced stimulation of glutamine synthetase activity (up to 10-fold above basal) in P10 than in E18 cultures (up to 2 times above basal). The differences in expression/inducibility of glutamate transporters and glutamine synthetase observed in astrocyte cultures derived from various stages of fetal and postnatal development suggest that astrocytes in vivo might also respond differently to environmental or injurious stimuli during development and maturation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10452361     DOI: 10.1016/s0736-5748(99)00028-3

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  15 in total

Review 1.  Astrocytic regulation of glutamate homeostasis in epilepsy.

Authors:  Douglas A Coulter; Tore Eid
Journal:  Glia       Date:  2012-05-16       Impact factor: 7.452

2.  Ontogenetic changes in glial fibrillary acid protein phosphorylation, glutamate uptake and glutamine synthetase activity in olfactory bulb of rats.

Authors:  Cíntia Eickhoff Battú; Graça F R S Godinho; Ana Paula Thomazi; Lúcia M V de Almeida; Carlos Alberto Gonçalves; Trícia Kommers; Susana T Wofchuk
Journal:  Neurochem Res       Date:  2005-09       Impact factor: 3.996

Review 3.  White-matter astrocytes, axonal energy metabolism, and axonal degeneration in multiple sclerosis.

Authors:  Melissa Cambron; Miguel D'Haeseleer; Guy Laureys; Ralph Clinckers; Jan Debruyne; Jacques De Keyser
Journal:  J Cereb Blood Flow Metab       Date:  2012-01-04       Impact factor: 6.200

4.  Anti-aging effects of guanosine in glial cells.

Authors:  Débora Guerini Souza; Bruna Bellaver; Larissa Daniele Bobermin; Diogo Onofre Souza; André Quincozes-Santos
Journal:  Purinergic Signal       Date:  2016-09-01       Impact factor: 3.765

5.  Heterogeneity of Astrocytes in Grey and White Matter.

Authors:  Susanne Köhler; Ulrike Winkler; Johannes Hirrlinger
Journal:  Neurochem Res       Date:  2019-12-03       Impact factor: 3.996

6.  Evidence for astrocytes as a potential source of the glutamate excess in temporal lobe epilepsy.

Authors:  Edgar L Perez; Fredrik Lauritzen; Yue Wang; Tih-Shih W Lee; Dewey Kang; Hitten P Zaveri; Farrukh A Chaudhry; Ole P Ottersen; Linda H Bergersen; Tore Eid
Journal:  Neurobiol Dis       Date:  2012-05-31       Impact factor: 5.996

7.  Recurrent seizures and brain pathology after inhibition of glutamine synthetase in the hippocampus in rats.

Authors:  Tore Eid; Arko Ghosh; Yue Wang; Henning Beckström; Hitten P Zaveri; Tih-Shih W Lee; James C K Lai; Gauri H Malthankar-Phatak; Nihal C de Lanerolle
Journal:  Brain       Date:  2008-07-06       Impact factor: 13.501

8.  Astrocyte-like cells derived from human oral mucosa stem cells provide neuroprotection in vitro and in vivo.

Authors:  Javier Ganz; Ina Arie; Tali Ben-Zur; Michal Dadon-Nachum; Sammy Pour; Shareef Araidy; Sandu Pitaru; Daniel Offen
Journal:  Stem Cells Transl Med       Date:  2014-01-29       Impact factor: 6.940

9.  The role of astrocytes in CNS tumors: pre-clinical models and novel imaging approaches.

Authors:  Emma R O'Brien; Clare Howarth; Nicola R Sibson
Journal:  Front Cell Neurosci       Date:  2013-04-16       Impact factor: 5.505

10.  Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2.

Authors:  Shannon R Hinson; Shanu F Roemer; Claudia F Lucchinetti; James P Fryer; Thomas J Kryzer; Jayne L Chamberlain; Charles L Howe; Sean J Pittock; Vanda A Lennon
Journal:  J Exp Med       Date:  2008-10-06       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.